Consenso de médicos expertos en HTA sobre el uso clínico de la triple terapia antihipertensiva a dosis fija en España

  1. P. Mazón 1
  2. E. Galve 2
  3. J. Gómez 3
  4. M. Gorostidi 4
  5. J.L. Górriz 5
  6. J.D. Mediavilla 6
  1. 1 Complexo Hospitalario Universitario de Santiago
    info

    Complexo Hospitalario Universitario de Santiago

    Santiago de Compostela, España

    ROR https://ror.org/00mpdg388

  2. 2 Hospital Vall d’Hebrón, España
  3. 3 Hospital Infanta Sofía, España
  4. 4 Hospital Universitario Central de Asturias, España
  5. 5 Hospital Universitario Dr. Peset, España
  6. 6 Hospital Virgen de las Nieves, España
Show affiliations +
Journal:
Hipertensión y riesgo vascular

ISSN: 1889-1837

Year of publication: 2016

Volume: 33

Issue: 4

Pages: 133-144

Type: Article

DOI: 10.1016/J.HIPERT.2016.03.001 DIALNET GOOGLE SCHOLAR

More publications in: Hipertensión y riesgo vascular

Abstract

Introduction The opinion of experts (different specialties) on the triple fixed-dose antihypertensive therapy in clinical practice may differ. Materials and methods Online questionnaire with controversial aspects of the triple therapy answered by panel of experts in hypertension (HT) using two-round modified Delphi method. Results The questionnaire was completed by 158 experts: Internal Medicine (49), Nephrology (26), Cardiology (83). Consensus was reached (agreement) on 27/45 items (60%); 7 items showed differences statistically significant. Consensus was reached regarding: Predictive factors in the need for combination therapy and its efficacy vs. increasing the dose of a pretreatment, and advantage of triple therapy (prescription/adherence/cost/pressure control) vs. free combination. Conclusions This consensus provides an overview of the clinical use of triple therapy in moderate-severe and resistant/difficult to control HT.

Data source: Dialnet